Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Coherus Announces Proposed Public Offering of Common Stock
-
Coherus Biosciences (CHRS) PT Raised to $22 at Maxim Group
-
Coherus Biosciences (CHRS) PT Raised to $18 at Maxim Group as Neulasta BLA Re-Submitted
-
Coherus Biosciences (CHRS) PT Lowered to $15 at Maxim Group
-
Coherus BioSciences (CHRS): TNF Removal Sparks PT Cut - Maxim
-
Coherus Biosciences (CHRS) PT Raised to $44 at Maxim Group; 'David Delivers a Blow to Goliath - Humira Patent '135 Falls'
-
Maxim Group Starts Coherus Biosciences (CHRS) at Buy
